Today's Daily Dose brings you news about Aerpio Pharma's clinical trial catalyst, Adicet Bio's reverse merger with resTORbio, FDA decision date of Ardelyx's Tenapanor, Cel-Sci's phase III study of Multikine for the treatment of newly diagnosed head and neck cancer, and an update on Pfizer's pipeline.
from RTT - Biotech https://ift.tt/3c3LtOo
via IFTTT
No comments:
Post a Comment